DIRS.INFO The most relevant business & tech news

☆ Women's health is gaining traction — and a top VC predicts a blockbuster IPO for Maven could pave the way for more transactions
▼ + stars: | 2023-12-26 | by ( Blake Dodge | ) www.businessinsider.com time to read: +4 min

Investors rely on "exits" such as initial public offerings when assigning valuations to similar companies, Farr said. So the lack of attractive data on this front is helping to hold back the women's health category as a whole, she said. "Depressed valuations are keeping the IPO window latched," the authors of the SVB report wrote. Maven ClinicWomen's health, long neglected by VCs, is gaining tractionHistorically, investment in women's health has lagged behind other parts of healthcare. More than 76% of women's health startups have at least one female cofounder, the SVB report said.

Persons: Chrissy Farr, Farr, Maven, Kate Ryder, SVB, Gina Bartasi Organizations: OMERS Ventures, Silicon Valley Bank, Business, Maven

☆ Why a giant health insurer merger is probably destined to fail
▼ + stars: | 2023-11-30 | by ( ) www.businessinsider.com time to read: +7 min

The giant health insurers Cigna and Humana are reportedly considering a merger. While they offer different kinds of health insurance, the deal is likely to face antitrust scrutiny. Still, Cigna and Humana did toy with a deal way back in 2014 before they pursued deals with other partners. Later, to sidestep antitrust scrutiny, health insurers eyed mergers with other pieces of the healthcare system outside of insurance. Cigna and Humana would face a more skeptical Justice DepartmentAny deal between health insurers the size of Cigna and Humana would have to get past the Justice Department's antitrust enforcers.

Persons: Biden, —, Justice that's, BofA, David Balto, Cigna, That's, Balto, Barak Richman, there's, Matthew Cantor, Constantine Cannon, divestitures aren't, Molina wouldn't, Cantor Organizations: Humana, Service, Reuters, Bloomberg, Street, Department, Justice, Cigna, UnitedHealth Group, Equity, Federal Trade Commission, Justice Department, Express, CVS Health, Aetna, Kindred, Biden Administration, FTC, Duke University Locations: Cigna, Aetna, Delaware

☆ Why Hims & Hers won't prescribe Ozempic for now in its new weight-loss program
▼ + stars: | 2023-11-27 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +2 min

When Hims & Hers launches its new weight-loss program, the digital-health company won't be joining in on the Ozempic craze, its CEO, Andrew Dudum, said. While pricey drugs like Ozempic and Wegovy have exploded in popularity this year for their potential to help people lose weight, Hims & Hers plans to offer cheaper generic medications for weight loss, at least initially. Ro's weight-loss program was fueling fast growth for the startup this year, but some patients struggled with insurance denials and delays in communication with Ro. Dudum said during the company's third-quarter earnings call that Hims & Hers expected weight management to be "an extraordinarily valuable category." Next year, in addition to launching its weight-loss program, the company plans to expand its new AI engine, which it's been beta testing in its psychiatry patients.

Persons: Andrew Dudum, Dudum, It's Organizations: Business

☆ What we'd like to see from 3 economic readings and 2 earnings reports next week
▼ + stars: | 2023-11-11 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

The major averages advanced again this week as earnings results came in largely better than expected, interest rates stabilized and oil prices dropped below $80 a barrel. Looking ahead, we'll get a couple more earnings results and some key inflationary data to chew on. In this past week, we bought 150 shares of DuPont (DD) and added 75 shares of Wynn Resorts (WYNN). As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stocks, Wynn Resort's, WYNN, we'll, That's, —, we're, it's, PANW, Tyson, Henry Schein, Spero, Sanara, Sara Lee Corp, JD.com, Woodward, Jim Cramer's, Jim Cramer, Jim, Mario Anzuoni Organizations: Nasdaq, Dow Jones, Coterra Energy, Emerson, Disney, PPI, TJX, Palo Alto Networks, DuPont, Wynn Resorts, WYNN, Tyson Foods, TSN, Tower Semiconductor, Partners, Genius Sports, Spero Therapeutics, Star Bulk Carriers Corp, Beauty Health, Asure, Gladstone Capital Corp, TeraWulf Inc, Harrow Health, Afya, Sea, Paysafe Group Holdings, Solar Inc, Aramark Holdings Corp, Lending, Holding, BioXcel Therapeutics, IHS Inc, Rewalk Robotics, Acurx Pharmaceuticals, Energizer Holdings, Power Solutions, Rekor Systems, Wine Estates, Momentus Inc, SIGMA Lithium Corporation, AlTi, QuickLogic Corporation, Arcturus Therapeutics, Dada Nexus, Solutions, Target Corp, Parts, ZIM Integrated Shipping Services, Alto Networks, Cisco Systems, Chemical & Mining Co, PennantPark Investment Corp, Copa Holdings S.A, Walmart, Arcos Dorados Holdings, ARCO, NICE, Body, Warner Music Group Corp, Ross Stores, Homes, Dolby Laboratories Inc, American Software, ESCO Technologies, ZTO, International, BJ's Wholesale, Jim Cramer's Charitable, CNBC, Maxx Locations: Macau, Chile, Cayman, Pasadena , California

☆ Sixty percent of major brands plan to increase their ad budgets in 2024, new research shows
▼ + stars: | 2023-11-07 | by ( Lara O'Reilly | ) www.businessinsider.com time to read: +4 min

Marketers have expressed cautious optimism looking ahead to 2024, with 60% of respondents in a new survey saying they plan to increase their ad budgets next year. Just 29% of respondents last year said they were expecting to increase their media budgets in 2023. Of the remaining 40% of those surveyed, roughly one-third (33%) said they intended to maintain their 2023 budgets into 2024. Meanwhile, print, linear TV, and radio were all likely to decline in their share of most marketers' budgets in 2024, according to the report. Around a third of advertisers said they plan to conduct log-level analysis of the programmatic supply chains in 2024 and 2025, according to the report.

Persons: Stephan Loerke, it's, we'll Organizations: World Federation, Retailers, CTV

☆ Stocks making the biggest moves before the bell: Uber, Planet Fitness, Peloton and more
▼ + stars: | 2023-11-07 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

Uber — Shares of the ride hailing company rose 2% after Uber's third-quarter gross bookings of $35.3 billion topped the company's guidance of $29 billion to $30 billion. Planet Fitness — The gym chain climbed 8.8% after beating expectations on both lines for the third quarter and raising its outlook for the year. Planet Fitness reported 59 cents in earnings per share, excluding items, and $277.6 million in revenue. Analysts surveyed by FactSet anticipated 55 cents in earnings per share on revenue at $268.2 million. It also cut its price target on Peloton to $4 from $13 per share, implying about 20% downside from Monday's close.

Persons: FactSet, Tripadvisor, Coterra, Sanmina, DigitalOcean, Goldman Sachs, —, Yun Li, Jesse Pound, Lisa Kailai Han, Sarah Min, Michelle Fox Organizations: UBS —, UBS, Credit Suisse, LSEG, Energy, —, Deutsche Bank Locations: Switzerland

☆ Stocks making the biggest moves after hours: TRIP, CTRA, IFF
▼ + stars: | 2023-11-06 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Tripadvisor reported adjusted earnings of 52 cents per share on $533 million in revenue, while analysts polled by LSEG forecast 47 cents per share and $505 million. Separately, IFF posted third-quarter adjusted earnings and revenue that beat analysts' estimates. Coterra Energy posted adjusted earnings of 50 cents per share in the third quarter, while analysts called for 44 cents a share, per FactSet. The company also raised its expectations for full-year adjusted earnings before interest, taxes, depreciation and amortization. Fabrinet posted adjusted earnings of $2 per share on $685.5 million in revenue, while analysts polled by FactSet anticipated $1.85 per share in earnings and $659.2 million of revenue.

Persons: Tripadvisor, who's, Sanmina, headwinds, Fabrinet, FactSet, Darla Mercado Organizations: LSEG, Vertex Pharmaceuticals, Icahn Capital, Coterra Energy, Management, FactSet

☆ ‘It all feels like a nightmare.’ This mom and former Israeli tank commander is leading her tech startup from a war zone
▼ + stars: | 2023-11-03 | by ( Matt Egan | ) edition.cnn.com time to read: +4 min

Cohen, a former tank commander in the Israeli Army, had no doubt she should immediately return to Tel Aviv. Now she is leading Hello Heart from Tel Aviv, where the company employs about 80 people. Other Hello Heart employees are Palestinians, including some who have family in Gaza. After the terror attack, Hello Heart consulted a trauma expert to help address the mental health stress. “I told our board we’re going to win the war against Hamas,” Cohen said.

Persons: New York CNN — Maayan Cohen, Cohen, ” Cohen, ”, ” ‘, ’ Cohen, I’ve, Maayan Cohen, Micha, you’re, Heart, “, “ We’re Organizations: New, New York CNN, Israeli Army, CNN, CVS, Delta Air Lines, Heart’s Tel, Hamas Locations: New York, Tel Aviv, Las Vegas, Israel, Vegas, American, Silicon Valley, California, Gaza, Heart’s, Heart’s Tel Aviv

☆ The 16 most valuable global AI companies in sports, plus other takeaways from new data on VC investment in the sector
▼ + stars: | 2023-10-19 | by ( Margaret Fleming | ) www.businessinsider.com time to read: +6 min

While generative AI startups are attracting more investment overall, 2023 could be a notably slow year for venture capital investment in sports AI following several years of activity, according to new data from PitchBook. The year could mark the lowest level of investment in the sector since 2018 when PitchBook tracked just under $200 million in VC activity. Both those years had 114 VC investments, compared to just 54 in 2023 through mid-October, PitchBook data shows. These are the top 16 highest-valued sports AI companies globally in 2023, according to PitchBook:1) SigmaStar — $4.55 billion. The Beijing-based computer vision technology company offers solutions in sports and health, evaluating movement in real-time, according to its website.

Persons: PitchBook, Hudl, STATSports, Creatz, Ligatech, Simplebet, Zepp Organizations: Yi Technology, WSC Sports, Cleveland Cavaliers, Kakao, Arsenal FC, US, National Soccer Team, Duke University, Kansas City Chiefs, Ligatech, Tempus, Francisco's Tempus, Chelsea FC, NFL, Sports, NBA, MLS, Premier League, AI Research Locations: deepfakes, Beijing, Israel, New York, Korean, Europe, Mexico, Lincoln , Nebraska, Northern Ireland, Shanghai, PitchBook, Los Angeles, China, Vancouver

BRUSSELS (AP) — The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in the 27-nation bloc. The EU already slapped a $475 million fine on Illumina over the summer for jumping the gun on the acquisition without its consent. Allowing the deal to stand would have undermined the credibility of EU regulators. The EU accused Illumina and Grail of knowingly and deliberately merging before getting clearance in what amounted to a vital infringement of the rules. Illumina must “restore the situation prevailing before” the acquisition, regulators said, and how Illumina divests itself of Grail also needs EU approval.

Persons: Didier Reynders, Illumina, ”, Grail Organizations: Union, Thursday, EU, Companies, European Commission, Illumina, Regulators, Federal Trade Commission Locations: BRUSSELS, EU, U.S, San Diego

☆ The healthcare venture firm behind Livongo just raised $217 million to back the next generation of digital-health giants
▼ + stars: | 2023-10-03 | by ( Blake Dodge | ) www.businessinsider.com time to read: +6 min

7wireVentures, a prominent venture-capital firm, just raised $217 million to fund the next generation of healthcare startups, bringing the firm's total assets under management to more than $500 million. The fund, which closed last Friday, is the biggest that 7wire has ever raised and represents a strategy shift for the firm. The startups Folx Health and Parsley Health, new investments for 7wire, have also won contributions from the new fund. Livongo7wire keeps funds and the portfolio size, just north of 20 startups, both relatively small, all managed by only four partners: Tullman, Jaffee, Shapiro, and Garber. The small size of the operation is intentional in keeping with 7wire's "quality over quantity" approach to investing, Garber said.

Persons: 7wire, Glen Tullman, Lee Shapiro, Alyssa Jaffee, Alyssa Jaffee Alyssa Jaffee, Jaffee, Tullman, Shapiro, Robert Garber, Livongo's, Livongo 7wire, Garber, Jaffe Organizations: Folx, Parsley Health Locations: Tullman

☆ Insider Today: The fight for remote jobs
▼ + stars: | 2023-09-26 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +8 min

Remote workers are doing anything but work in the afternoons. Elena Noviello/Getty ImagesThere are few topics in corporate America as polarizing as remote work. AdvertisementAdvertisementLengthy, expensive office leases might also discourage companies from embracing remote work. As Aki's story points out, that type of rationale from larger companies has created an opportunity for those willing to support remote work. A company's commitment to remote work might not be forever, even if employees view it that way.

Persons: —, Taylor Swift, Travis Kelce, we've, I'm, Chelsea Jia Feng, Insider's Aki Ito, Aki, What's, Elena Noviello, Goldman Sachs, Leonardo Munoz, Rebecca Szkutak, Dominic, Madori Davis, Snyder, Mark Reinertson, Anthropic, Lindsey Nicholson, Jacob Boomsma, Dan DeFrancesco, Naga Siu, Hallam Bullock, Lisa Ryan Organizations: Service, NFL, nab, TechCrunch, Thistle Technologies, Getty, Employees, Costco, Google, Netflix, Cintas Corp Locations: America, Amazon's, Sioux Falls , South Dakota, Jefferson City , Missouri, New York City, San Diego, London, New York

☆ 'Shark Tank' investor Kevin O'Leary likely made over 20 times his money on a startup selling genetic-testing kits for cats
▼ + stars: | 2023-09-23 | by ( Theron Mohamed | ) www.businessinsider.com time to read: +3 min

Kevin O'Leary probably made over 20 times his money from one "Shark Tank" investment. The celebrity investor backed Basepaws, a startup selling at-home genetic tests for cats, when it was pitched on "Shark Tank" in 2019. O'Leary said on "The Daniel Mac Show" earlier this year that among his "Shark Tank" investments, Basepaws was his biggest winner in percentage terms. If O'Leary paid $125,000 for a 5% stake, he would have made about $2.4 million or 20 times his money, ignoring any dilution. "She's so good at promoting her products, she has built that business 10-fold since 'Shark Tank.'"

Persons: Kevin O'Leary, Basepaws, Zoetis, O'Leary, Anna Skaya, Robert Herjavec, Daniel Mac, —, Zoetis didn't, Anna Organizations: Service, Basepaws, Albertsons Locations: Basepaws, Wall, Silicon

☆ Home tests still work to detect Covid-19, but here’s why your test may not pick up an infection
▼ + stars: | 2023-09-18 | by ( Brenda Goodman | ) edition.cnn.com time to read: +9 min

That has led to speculation on social media that perhaps rapid tests have lost their ability to detect some of the newer coronavirus variants. “To date, the performance of currently marketed COVID-19 tests has not been adversely impacted by any new variants,” Merchak said in a statement. “That’s why the repeat testing 48 hours is so important.”Why rapid tests are often negative in kidsAnother real-world study of rapid tests identified another reason the tests sometimes don’t work well: operator error. In this study, negative rapid tests correctly meant that a child was healthy only 38% of the time. PCR tests showed that the infected kids had viral loads that should have been high enough to turn positive on rapid tests.

Persons: ”, Michael Mina, Mina, Todd Merchak, ” Merchak, ” Mina, won’t, “, Nathaniel Hafer, ” Hafer, Taiwan hadn’t, Dr, Sanjay Gupta, he’s Organizations: CNN, telltale, Twitter, National Institutes of Health, US Food and Drug Administration, Cell, RADx, FDA, CDC, University of Massachusetts, UMass Chan Medical, Rapid, CNN Health Locations: Taiwan

☆ Walgreens just made another big bet on healthcare, weeks after its CEO exited. A top exec shares how the company plans to partner with doctors.
▼ + stars: | 2023-09-12 | by ( ) www.businessinsider.com time to read: +5 min

In an interview with Insider, the head of Walgreens Health shared his vision for the business. It spent $5.2 billion to buy a majority stake in the primary-care company VillageMD and invested $3.5 billion to help the clinic chain acquire an urgent-care company. The company reported in June an operating loss of $1.4 billion in its Walgreens Health business in the first nine months of its fiscal year. Walgreens pharmacists could work with VillageMD doctors to better care for patients with chronic health conditions, he said. Integrating Walgreens' healthcare businessesWalgreens' strategy for how it would tie its growing number of individual healthcare businesses together hasn't been clear, but Driscoll gave some clues.

Persons: Rosalind Brewer, Brewer, James Kehoe, John Driscoll, Walgreens, Driscoll, Pearl Organizations: Walgreens, Walgreens Health, Shields Health Solutions, Pearl Health, CVS, Health, Amazon, Walmart Locations: Shields, Pearl

☆ Testosterone parties are the latest biohack for Silicon Valley tech bros
▼ + stars: | 2023-09-10 | by ( Lakshmi Varanasi | ) www.businessinsider.com time to read: +5 min

It hosts testosterone blood-test "T Parties" with tickets costing from $100 to $400. Get the inside scoop on today’s biggest stories in business, from Wall Street to Silicon Valley — delivered daily. He later told Insider in a message on X that his qualifications include "personal experience boosting my T from 790 to 1090 and peer-reviewed research." In May, Tang held a "T Party" in Colombia where he tested 24 men, according to a post on X. Beyond that, Vinjamoori noted that "a single-minded focus on testosterone might not offer the well-rounded approach needed for optimal health and longevity."

Persons: Jeff Tang, Tang, he'd, it's, Anant Vinjamoori, Vinjamoori, he's, Bryan Johnson's Organizations: Service, Party, Athens Research Locations: Athens, Wall, Silicon, San Francisco, Colombia

☆ Nvidia, JNJ, and more: CNBC's 'Halftime Report' traders answer your questions
▼ + stars: | 2023-09-07 | by ( Christina Falso | ) www.cnbc.com time to read: 1 min

On Thursday's "Ask Halftime," traders answered questions from CNBC Pro subscribers about which stocks and commodities to buy, hold or sell right now. Jim Lebenthal of Cerity Partners explained why the dip in Nvidia 's share price is a great buying opportunity right now. Hightower Advisors' Stephanie Link sees more upside for Johnson & Johnson 's stock but said its consumer health company spinoff, Kenvue , is still too expensive. Finally, Bill Baruch of Blue Line Futures owns Cameco Corp. and explained why the uranium miner is a solid stock to have in your portfolio.

Persons: Jim Lebenthal, Hightower, Stephanie Link, Johnson, Bill Baruch Organizations: CNBC Pro, Cerity Partners, Nvidia, Hightower Advisors, Johnson, Blue Line, Cameco Corp

☆ Inside the struggles at Calibrate, a new kind of weight-loss startup that's facing a mountain of patient complaints and refunds
▼ + stars: | 2023-09-05 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +19 min

Weight-loss startup Calibrate has struggled to get patients access to buzzy drugs like Ozempic. Kenyon's startup Calibrate, which she launched in June 2020, is one of the healthcare companies feeding the frenzy. CalibrateThe company is now running up against several massive challenges: Weight-loss drugs are expensive and in short supply, and health insurers are increasingly reluctant to pay for them. Kenyon said about 20% of Calibrate members do not have coverage for weight-loss medications, and around half of those people request refunds from Calibrate. Want to tell us about your experience with Calibrate or weight-loss drugs?

Persons: lightbulb, Isabelle Kenyon, Kenyon, Jenny Craig, OptumRx, She's, she's, Saxenda, —, weren't, It's, they've, Holly, hadn't, hasn't, Claire Rosenzweig, Rosenzweig, it's, Andrew Kelly, Shelby Livingston, Rebecca Torrence Organizations: New, Tiger Global, Founders Fund, Optum Ventures, FedEx, Food and Drug Administration, Jefferies, Better Business Bureau, BBB, Better Business, Metropolitan New, Better, Apple, Businessolver, Optum, UnitedHealth, Employees, REUTERS, Madryn Asset Management, SM Ventures, Ventures Locations: America, New York, Danish, GLP, Florida, Metropolitan New York, slivingston@insider.com, rtorrence@insider.com

☆ J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff
▼ + stars: | 2023-08-30 | by ( ) www.reuters.com time to read: +1 min

Johnson & Johnson company offices are shown in Irvine, California, U.S., October 14, 2020. REUTERS/Mike Blake Acquire Licensing RightsAug 30 (Reuters) - Johnson & Johnson (JNJ.N) on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue (KVUE.N) . J&J also said it would present its consumer health business as discontinued operations and record a gain of $20 billion in the third quarter as a result of the spinoff. It expects 2023 adjusted reported earnings per share of $10.00 - $10.10, 12.5% higher at the midpoint compared with 2022. Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalization of about $78.9 billion.

Persons: Johnson, Mike Blake, J, Kenvue, Manas Mishra, Devika Organizations: Johnson, REUTERS, New York Stock Exchange, Thomson Locations: Irvine , California, U.S, Bengaluru

☆ Wait, Is That Rapid Test Really Expired?
▼ + stars: | 2023-08-29 | by ( Dani Blum | More About Dani Blum | ) www.nytimes.com time to read: +2 min

If a test is delivered to you on a sweltering day, for example, the agency recommends bringing the package inside and waiting at least two hours before opening it. And always make sure the control line — which typically appears next to the “C” — shows up when you use a rapid test; otherwise, the test may be damaged or faulty. If you have Covid symptoms and someone you had been spending time with is now positive, test immediately. says to wait at least five days before testing because swabbing too early can give you a false negative. “Especially people who have been recently boosted,” he said, “if they get infected, they might become symptomatic 24 hours post-exposure, 48 hours post-exposure — really fast.”

Persons: Peter Chin, Sala, . Chin, Hong, Michael Mina, Harvard epidemiologist, ” Organizations: University of California, Harvard Locations: San Francisco

☆ Here are Monday's biggest analyst calls: Tesla, Netflix, Disney, Amazon, Alphabet, Nike, Costco & more
▼ + stars: | 2023-08-28 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

UBS reiterates Netflix as buy UBS said it's standing by its buy rating on shares of the streaming giant. Morgan Stanley reiterates Ambarella as overweight Morgan Stanley said it's bullish on shares of the semiconductor company heading into earnings this week. " UBS reiterates Disney as buy UBS said it's standing by its buy rating on shares of the entertainment giant. Morgan Stanley downgrades CrowdStrike to equal weight from overweight Morgan Stanley said it's cautious heading into earnings later this week. Morgan Stanley names LifeStance Health Group a top pick Morgan Stanley said shares of the behavioral health company are compelling.

Persons: Tesla, Canaccord, it's bullish, it's, Morgan Stanley, Ambarella, JMP, Piper Sandler, Piper, Bernstein, L3Harris, Evercore, Jefferies, Morgan Stanley downgrades CrowdStrike, Zimmer, BTIG, Wells, Dwight, Truist, Wolfe, Stifel, defensives Organizations: UBS, Netflix, Disney, Pagaya Technologies, MCW, OW, JetBlue, " Bank of America, Bank of America, Akero Therapeutics, RBC, Tetra Tech, Tech, Amazon, LifeStance Health, Mobility, UGI Corporation, TAM, Nike, NIKE, Endeavor Group, Media, Entertainment, Costco, AutoZone, Walmart Locations: China, Underperform, ORLY

☆ J&J to hold 9.5% stake in Kenvue after share exchange offer
▼ + stars: | 2023-08-21 | by ( ) www.reuters.com time to read: 1 min

The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on during the company's IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsAug 21 (Reuters) - Johnson & Johnson (JNJ.N) said on Monday it was expecting to retain a stake of about 9.5% in its newly separated consumer health unit, Kenvue (KVUE.N), after completing a share exchange offer. Shares of the consumer health company rose 1.4% in premarket trading. ‍J&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff. Reporting by Bhanvi Satija and Mariam Sunny in Bengaluru; Editing by Anil D'SilvaOur Standards: The Thomson Reuters Trust Principles.

Persons: Brendan McDermid, Johnson, ‍, J, Bhanvi Satija, Mariam Sunny, Anil D'Silva Organizations: Kenvue Inc, Johnson, New York Stock Exchange, REUTERS, Thomson Locations: New York City, U.S, Bengaluru

☆ Here's everything you need to know about ChatGPT, the chatbot everyone's still talking about
▼ + stars: | 2023-08-19 | by ( Sindhu Sundar | ) www.businessinsider.com time to read: +6 min

ChatGPT has drawn users at a feverish pace and spurred Big Tech to release other AI chatbots. But ChatGPT, the latest in technology known as "large language model tools," doesn't speak with sentience and doesn't "think" the way people do. Other tech companies like Google and Meta have developed their own large language model tools, which use programs that take in human prompts and devise sophisticated responses. Other researchers seem to be taking more measured approaches with generative AI tools. He told Insider he's helping to experiment with a chat bot called "Rentervention," which is meant to support tenants.

Persons: ChatGPT, Here's, what's, OpenAI, Matthew Sag, Koko, Rob Morris, Daniel Linna Jr, he's, Linna Organizations: Big Tech, Microsoft, Emory University, Google, Northwestern University, Committee, Better, Princeton

☆ Stocks making the biggest moves after hours: Chegg, Beyond Meat, Paramount Global, Celanese and more
▼ + stars: | 2023-08-07 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

Chegg notched second-quarter revenue of $183 million, while analysts polled by Refinitiv had expected $177 million. Analysts polled by Refinitiv called for a 5 cent loss per share and revenue of $205 million. Paramount Global — The media conglomerate added almost 4% in extended trading hours after posting an earnings and revenue beat. In the second quarter, the company reported $150.9 million in revenue against analysts' estimate of $175 million, per Refinitiv. Celanese — The materials stock fell nearly 3% after missing on both the top and bottom line in the second quarter.

Persons: Chegg, Refinitiv, Celanese Organizations: Paramount Global

☆ 'Realistic, not frothy': Investor says S&P 500 will hit 5,000, names stocks to buy in that scenario
▼ + stars: | 2023-08-03 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Some on Wall Street are getting increasingly bullish on the S & P 500 , raising their price targets for the index. It increased its year-end S & P 500 price target from 4,400 to 4,900 — the highest in CNBC's Market Strategist survey . Mid-cap tech stocks : Ball said "mid tech is the equity place for tomorrow." Big tech stocks have contributed to much of the gains this year — although the rally is broadening out — but other well established "but not gigantic" tech stocks have "more premise looking ahead." Energy stocks: The S & P 500 energy subsector has underperformed this year, gaining just 1% to date.

Persons: Sanders Morris Harris, George Ball, CNBC's, Ball Organizations: Oppenheimer Asset Management, CNBC's, Citi, Trade, Energy, Enterprise Products Partners Locations: Tuesday's, bitcoin

Search resuls for: "Health Company"

25 mentions found